Yoder Stephen S.

Pieris Pharmaceuticals, Inc.

Chief Executive Officer, Director

Avg. Two Year Performance

240% Avg. Purchase Return 84% Compound

No Sale Track Record

Holdings: 6.0K shares

Last Three Months: 15-Mar-24 -- 14-Jun-24

0 Net Amount

Buy:	0	--
Sell:	0	--

Sentiment

Company Sentiment

Biotechnology

Drugs

Two Year Chart

15-Jun-22 -- 14-Jun-24

Price ($)

Two Year Stock Price Chart

Sentiment

Company Sentiment

Most Recent Insider Transactions